{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:08:25Z","timestamp":1778476105187,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,10]]},"DOI":"10.7759\/cureus.108612","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:22:25Z","timestamp":1778473345000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypercalcemia, Staghorn Calculus and Xanthogranulomatous Pyelonephritis: A Diagnostic Challenge Unmasking Metastatic Urothelial Carcinoma"],"prefix":"10.7759","author":[{"given":"Jeanne Li Wen","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene Yuen Lin","family":"Yii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhel","family":"Sachdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2022.11.004","article-title":"Xanthogranulomatous pyelonephritis - a diagnostic and therapeutic dilemma","volume":"365","author":"Jang TL","year":"2023","unstructured":"Jang TL, McKoy T, Hakim J, Polenakovik HM. Xanthogranulomatous pyelonephritis - a diagnostic and therapeutic dilemma. Am J Med Sci. 2023, 365:294-301. 10.1016\/j.amjms.2022.11.004","journal-title":"Am J Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(78)90158-9","article-title":"Xanthogranulomatous pyelonephritis masquerading as occult malignancy","volume":"11","author":"Gerber WL","year":"1978","unstructured":"Gerber WL, Catalona WJ, Fair WR, Michigan S, Melson L. Xanthogranulomatous pyelonephritis masquerading as occult malignancy. Urology. 1978, 11:466-71. 10.1016\/0090-4295(78)90158-9","journal-title":"Urology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2113128","article-title":"Cancer-associated hypercalcemia","volume":"386","author":"Guise TA","year":"2022","unstructured":"Guise TA, Wysolmerski JJ. Cancer-associated hypercalcemia. N Engl J Med. 2022, 386:1443-51. 10.1056\/NEJMcp2113128","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4250","article-title":"PTHrP-mediated hypercalcemia: causes and survival in 138 patients","volume":"100","author":"Donovan PJ","year":"2015","unstructured":"Donovan PJ, Achong N, Griffin K, Galligan J, Pretorius CJ, McLeod DS. PTHrP-mediated hypercalcemia: causes and survival in 138 patients. J Clin Endocrinol Metab. 2015, 100:2024-9. 10.1210\/jc.2014-4250","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2024.09.003","article-title":"Association between parathyroid hormone-related peptide levels and mortality in patients with malignancy","volume":"30","author":"Kimura A","year":"2024","unstructured":"Kimura A, Kato K, Nakashima A, Maruyama Y, Ohkido I, Miyazaki Y, Yokoo T. Association between parathyroid hormone-related peptide levels and mortality in patients with malignancy. Endocr Pract. 2024, 30:1119-25. 10.1016\/j.eprac.2024.09.003","journal-title":"Endocr Pract"},{"key":"ref6","article-title":"Understanding the link between kidney stones and cancers of the upper urinary tract and bladder","volume":"10","author":"Mihalopoulos M","year":"2022","unstructured":"Mihalopoulos M, Yaghoubian A, Razdan S, et al.. Understanding the link between kidney stones and cancers of the upper urinary tract and bladder. Am J Clin Exp Urol. 2022, 10:277-98.","journal-title":"Am J Clin Exp Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-025-01758-5","article-title":"Increased risk of upper tract urothelial carcinoma in patients with kidney stones: a large-scale analysis of the UK biobank","volume":"53","author":"Ziadeh H","year":"2025","unstructured":"Ziadeh H, Calaway A, Gupta S, Bodner D, Brown JR, Schumacher FR, Wu CW. Increased risk of upper tract urothelial carcinoma in patients with kidney stones: a large-scale analysis of the UK biobank. Urolithiasis. 2025, 53:87. 10.1007\/s00240-025-01758-5","journal-title":"Urolithiasis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0356-7","article-title":"Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands Cohort Study","volume":"120","author":"van de Pol JA","year":"2019","unstructured":"van de Pol JA, van den Brandt PA, Schouten LJ. Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands Cohort Study. Br J Cancer. 2019, 120:368-74. 10.1038\/s41416-018-0356-7","journal-title":"Br J Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.18.8293","article-title":"Retrospective evaluation of risk factors and immunohistochemical findings for pre-neoplastic and neoplastic lesions of upper urinary tract in patients with chronic nephrolithiasis","volume":"16","author":"Desai FS","year":"2015","unstructured":"Desai FS, Nongthombam J, Singh LS. Retrospective evaluation of risk factors and immunohistochemical findings for pre-neoplastic and neoplastic lesions of upper urinary tract in patients with chronic nephrolithiasis. Asian Pac J Cancer Prev. 2015, 16:8293-8. 10.7314\/apjcp.2015.16.18.8293","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1001011","article-title":"Clinical practice. Calcium kidney stones","volume":"363","author":"Worcester EM","year":"2010","unstructured":"Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med. 2010, 363:954-63. 10.1056\/NEJMcp1001011","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-052521-121822","article-title":"Mechanisms underlying calcium nephrolithiasis","volume":"84","author":"Alexander RT","year":"2022","unstructured":"Alexander RT, Fuster DG, Dimke H. Mechanisms underlying calcium nephrolithiasis. Annu Rev Physiol. 2022, 84:559-83. 10.1146\/annurev-physiol-052521-121822","journal-title":"Annu Rev Physiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.07.089","article-title":"Changing composition of staghorn calculi","volume":"186","author":"Viprakasit DP","year":"2011","unstructured":"Viprakasit DP, Sawyer MD, Herrell SD, Miller NL. Changing composition of staghorn calculi. J Urol. 2011, 186:2285-90. 10.1016\/j.juro.2011.07.089","journal-title":"J Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-024-04816-6","article-title":"International Alliance of Urolithiasis (IAU) guideline on staghorn calculi management","volume":"42","author":"Zhong W","year":"2024","unstructured":"Zhong W, Osther P, Pearle M, et al.. International Alliance of Urolithiasis (IAU) guideline on staghorn calculi management. World J Urol. 2024, 42:189. 10.1007\/s00345-024-04816-6","journal-title":"World J Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3941\/jrcr.v12i11.3415","article-title":"Bear paw sign: xanthogranulomatous pyelonephritis","volume":"12","author":"Garrido-Abad P","year":"2018","unstructured":"Garrido-Abad P, Rodr\u00edguez-Cabello M\u00c1, Vera-Ber\u00f3n R, Platas-Sancho A. Bear paw sign: xanthogranulomatous pyelonephritis. J Radiol Case Rep. 2018, 12:18-24. 10.3941\/jrcr.v12i11.3415","journal-title":"J Radiol Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000473459","article-title":"Association of renal xanthogranuloma and urological neoplasia","volume":"15","author":"Ballesteros JJ","year":"1988","unstructured":"Ballesteros JJ, Munne A, Rivalta T, Palma C, Manzano I. Association of renal xanthogranuloma and urological neoplasia. Eur Urol. 1988, 15:306-10. 10.1159\/000473459","journal-title":"Eur Urol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-232097","article-title":"Xanthogranulomatous pyelonephritis with associated renal cell carcinoma","volume":"12","author":"Moss BF","year":"2019","unstructured":"Moss BF, Potter L, Cliff A, Kumar M. Xanthogranulomatous pyelonephritis with associated renal cell carcinoma. BMJ Case Rep. 2019, 12:e232097. 10.1136\/bcr-2019-232097","journal-title":"BMJ Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/003655902317259418","article-title":"Xanthogranulomatous pyelonephritis - the \"great imitator\" justifies its name","volume":"36","author":"Zorzos I","year":"2002","unstructured":"Zorzos I, Moutzouris V, Petraki C, Katsou G. Xanthogranulomatous pyelonephritis - the \"great imitator\" justifies its name. Scand J Urol Nephrol. 2002, 36:74-6. 10.1080\/003655902317259418","journal-title":"Scand J Urol Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21424","article-title":"Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens","volume":"122","author":"Brandler TC","year":"2014","unstructured":"Brandler TC, Aziz MS, Rosen LM, Bhuiya TA, Yaskiv O. Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens. Cancer Cytopathol. 2014, 122:468-73. 10.1002\/cncy.21424","journal-title":"Cancer Cytopathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000143","article-title":"Uroplakin II (UPII), GATA3, and P40 are highly sensitive markers for the differential diagnosis of invasive urothelial carcinoma","volume":"23","author":"Hoang LL","year":"2015","unstructured":"Hoang LL, Tacha D, Bremer RE, Haas TS, Cheng L. Uroplakin II (UPII), GATA3, and P40 are highly sensitive markers for the differential diagnosis of invasive urothelial carcinoma. Appl Immunohistochem Mol Morphol. 2015, 23:711-16. 10.1097\/PAI.0000000000000143","journal-title":"Appl Immunohistochem Mol Morphol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485067-hypercalcemia-staghorn-calculus-and-xanthogranulomatous-pyelonephritis-a-diagnostic-challenge-unmasking-metastatic-urothelial-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:22:26Z","timestamp":1778473346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485067-hypercalcemia-staghorn-calculus-and-xanthogranulomatous-pyelonephritis-a-diagnostic-challenge-unmasking-metastatic-urothelial-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,10]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.108612","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,10]]}}}